Palinta, Baby Boy .
HRN: 22-35-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
AMPICILLIN 250MG (VIAL)
12/25/2022
12/31/2022
IV
105 Mg
Q12h
Neonatal Sepsis NID
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes